Perluxan, a proprietary extract of hops cones clinically shown to reduce joint discomfort, will be marketed exclusively by Proprietary Nutritionals, Inc. (PNI), according to Dean Mosca, president.
“Initial research on Perluxan has been very promising, and we feel it is a great complement to the strong line of brands currently being marketed by PNI,” said Mosca.
Greg Bonfilio, who spearheaded development of Perluxan, will work closely with Mosca to advance the science and applications of the ingredient. For more information go to www.perluxan.com.
Proprietary Nutritionals, Inc., a subsidiary of Pharmachem Laboratories, Inc markets a variety of patented, scientifically proven, branded ingredients to the nutrition industry, including Benexia™ Chia Seed, Celadrin® Joint Flexibility & Relief, Sytrinol® Healthy Heart, and the Berry-Max® line of potent berry concentrates, including Cran-Max®, Blue-Max®, Bil-Max®, Elder-Max®, Cherry-Max®, and Pom-Max®. For further information, contact [email protected]